Scotiabank Maintains Sector Outperform on Aura Biosciences, Raises Price Target to $23

Benzinga · 10/18 15:26
Scotiabank analyst George Farmer maintains Aura Biosciences (NASDAQ:AURA) with a Sector Outperform and raises the price target from $20 to $23.